MAPT and Alzheimer disease: Earlier correlation studies of CSF tau and Aβ levels in neuropathologically verified DLB with concomitant AD pathology showed that both the extent of NFT pathology (Braak stage) and AD stage were inversely correlated with CSF Aβ-42 levels, whereas CERAD stage (neuritic plaques) showed no significant correlation.